Capital formation challenges in the industry have forced many biotech companies to halt projects, lay off staff or shutdown all together. Our analysis shows that the industry is approximately one-quarter smaller than it was in 2008.
|
June 7, 2012
|
June 6, 2012
|
June 6, 2012
|
June 1, 2012
|
|
May 29, 2012
|
May 29, 2012
|
May 18, 2012
|
May 17, 2012
|